Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_assertion type Assertion NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_head.
- NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_assertion description "[The genetic contribution to the development of ALL is examined by association studies that analyze the loci of Phase I enzymes (cytochrome P-450, myeloperoxidase) and Phase II enzymes (quinone-oxidoreductase, glutathione-S-transferase, N-acetyltransferase).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_provenance.
- NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_assertion evidence source_evidence_literature NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_provenance.
- NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_assertion SIO_000772 12041882 NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_provenance.
- NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_assertion wasDerivedFrom befree-2016 NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_provenance.
- NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_assertion wasGeneratedBy ECO_0000203 NP356649.RALXE2yszVvruTozuJ2wUqzCI1jCgNVVkFRozWCADb1kQ130_provenance.